Download PDF
Thromb Haemost 2019; 119(06): 941-951
DOI: 10.1055/s-0039-1683913
Blood Cells, Inflammation and Infection
Georg Thieme Verlag KG Stuttgart · New York

Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia

Madeleine Hui
1   Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
,
Jo-Ann I. Sheppard
1   Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
,
Na Li
2   McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
,
Theodore E. Warkentin
1   Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
2   McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
3   Department of Medicine, McMaster University, Hamilton, Ontario, Canada
4   Hamilton Regional Laboratory Medicine Program, Hamilton General Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada
› Author Affiliations
Further Information

Publication History

15 October 2018

07 February 2019

Publication Date:
20 April 2019 (online)

    Permissions and Reprints

Abstract

Background Heparin-induced thrombocytopenia (HIT) antibodies activate platelets, monocytes and neutrophils. Despite these findings, it is unknown whether white blood cell (WBC) counts, including neutrophils and monocytes, are altered during HIT.

Materials and Methods We evaluated changes in total WBC counts (including WBC subsets), in 50 post-cardiac surgery patients with serologically confirmed HIT (30 patients with HIT-associated thrombosis). Daily leukocyte counts were compared with those measured one day prior to HIT onset; WBC increases were classified as mild (20.0–49.9%), moderate (50.0–99.9%) or major (≥ 100% increase). We also compared changes in WBC counts in HIT patients with and without HIT-associated thrombosis, and non-HIT patients with thrombosis.

Results Most (34/50 [68.0%]) patients with HIT developed WBC count increases (mild, 35.3%; moderate, 44.1%; major, 20.6%). The peak WBC count occurred on day 4 (median) of HIT, which corresponded to day 10 (median) post-surgery. Absolute neutrophil counts increased in most patients (38/50 [76.0%]); whereas absolute monocyte counts rose in some patients, the overall tendency was for the monocyte count to decrease during HIT. Unexpectedly, we found that the increase in total WBC counts, as well as in neutrophils, was seen mainly in patients who developed HIT-associated or non-HIT-associated thrombosis; in contrast, no difference in monocyte levels was seen in patients with or without thrombosis.

Conclusion Leukocytosis and neutrophilia are commonly observed in patients with HIT, particularly in patients with HIT-associated thrombosis, as well as non-HIT patients with thrombosis. Thus, leukocytosis/neutrophilia should not infer automatically a diagnosis of infection or inflammation, when evaluating thrombocytopenia in heparin-exposed patients.

Keywords

heparin-induced thrombocytopenia - leukocytes - monocytes - neutrophils - thrombosis

Authors' Contributions

M.H. reviewed literature on WBC studies involving HIT, and collected WBC count data; T.E.W. designed the study and oversaw its conduct, collected and reviewed WBC count data, and wrote the first draft of the manuscript; J.I.S. performed data analyses and prepared the figures; N.L. performed statistical analyses; all authors reviewed and approved the final manuscript.


 

  • References

  • 1 Greinacher A. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 2015; 373 (03) 252-261
    CrossrefPubMedGoogle Scholar
  • 2 McMahon CM, Cuker A. Hospital-acquired thrombocytopenia. Hosp Pract (1995) 2014; 42 (04) 142-152
    CrossrefPubMedGoogle Scholar
  • 3 Bakchoul T. An update on heparin-induced thrombocytopenia: diagnosis and management. Expert Opin Drug Saf 2016; 15 (06) 787-797
    CrossrefPubMedGoogle Scholar
  • 4 Amiral J, Bridey F, Dreyfus M. , et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68 (01) 95-96
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Kelton JG, Smith JW, Warkentin TE, Hayward CPM, Denomme GA, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994; 83 (11) 3232-3239
    CrossrefPubMedGoogle Scholar
  • 6 Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994; 71 (02) 247-251
    PubMedGoogle Scholar
  • 7 Kelton JG, Sheridan D, Santos A. , et al. Heparin-induced thrombocytopenia: laboratory studies. Blood 1988; 72 (03) 925-930
    CrossrefPubMedGoogle Scholar
  • 8 Chong BH, Fawaz I, Chesterman CN, Berndt MC. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 1989; 73 (02) 235-240
    CrossrefPubMedGoogle Scholar
  • 9 Reilly MP, Taylor SM, Hartman NK. , et al. Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA. Blood 2001; 98 (08) 2442-2447
    CrossrefPubMedGoogle Scholar
  • 10 Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344 (17) 1286-1292
    CrossrefPubMedGoogle Scholar
  • 11 Lubenow N, Kempf R, Eichner A, Eichler P, Carlsson LE, Greinacher A. Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin. Chest 2002; 122 (01) 37-42
    CrossrefPubMedGoogle Scholar
  • 12 Warkentin TE, Levine MN, Hirsh J. , et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332 (20) 1330-1335
    CrossrefPubMedGoogle Scholar
  • 13 Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 2003; 163 (20) 2518-2524
    CrossrefPubMedGoogle Scholar
  • 14 Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 2005; 94 (01) 132-135
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Madeeva D, Cines DB, Poncz M, Rauova L. Role of monocytes and endothelial cells in heparin-induced thrombocytopenia. Thromb Haemost 2016; 116 (05) 806-812
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Pouplard C, Iochmann S, Renard B. , et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 2001; 97 (10) 3300-3302
    CrossrefPubMedGoogle Scholar
  • 17 Arepally GM, Mayer IM. Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8. Blood 2001; 98 (04) 1252-1254
    CrossrefPubMedGoogle Scholar
  • 18 Rauova L, Hirsch JD, Greene TK. , et al. Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia. Blood 2010; 116 (23) 5021-5031
    PubMedGoogle Scholar
  • 19 Tutwiler V, Madeeva D, Ahn HS. , et al. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia. Blood 2016; 127 (04) 464-472
    CrossrefPubMedGoogle Scholar
  • 20 Dai J, Madeeva D, Hayes V. , et al. Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia. Blood 2018; 132 (07) 727-734
    PubMedGoogle Scholar
  • 21 Khairy M, Lasne D, Amelot A. , et al. Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole blood. Thromb Haemost 2004; 92 (06) 1411-1419
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Warkentin TE. Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia. Thromb Haemost 2016; 116 (05) 813-822
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Visentin GP, Moghaddam M, Beery SE, McFarland JG, Aster RH. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis. J Lab Clin Med 2001; 138 (01) 22-31
    CrossrefPubMedGoogle Scholar
  • 24 Horsewood P, Warkentin TE, Hayward CPM, Kelton JG. The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol 1996; 95 (01) 161-167
    CrossrefPubMedGoogle Scholar
  • 25 Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67 (01) 27-30
    CrossrefPubMedGoogle Scholar
  • 26 Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I. Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL® HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia. Thromb Res 2017; 153: 108-117
    CrossrefPubMedGoogle Scholar
  • 27 Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I. Platelet-activating antibodies are detectable at the earliest onset of heparin-induced thrombocytopenia, with implications for the operating characteristics of the serotonin-release assay. Chest 2018; 153 (06) 1396-1404
    CrossrefPubMedGoogle Scholar
  • 28 Warkentin TE, Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T's score. J Thromb Haemost 2010; 8 (07) 1483-1485
    CrossrefPubMedGoogle Scholar
  • 29 Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003; 76 (06) 2121-2131
    CrossrefPubMedGoogle Scholar
  • 30 Lamm G, Auer J, Weber T, Berent R, Ng C, Eber B. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 2006; 20 (01) 51-56
    CrossrefPubMedGoogle Scholar
  • 31 Jacob KA, Buijsrogge MP, Frencken JF. , et al. White blood cell count and new-onset atrial fibrillation after cardiac surgery. Int J Cardiol 2017; 228: 971-976
    CrossrefPubMedGoogle Scholar
  • 32 Gee K. Multilevel growth modeling: an introductory approach to analyzing longitudinal data for evaluators. Am J Eval 2014; 35: 543-561
    CrossrefPubMedGoogle Scholar
  • 33 Haile LA, Rao R, Polumuri SK. , et al. PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses. Thromb Res 2017; 159: 39-47
    CrossrefPubMedGoogle Scholar
  • 34 Campello E, Radu CM, Duner E. , et al. Activated platelet-derived and leukocyte-derived circulating microparticles and the risk of thrombosis in heparin-induced thrombocytopenia: a role for PF4-bearing microparticles?. Cytometry B Clin Cytom 2018; 94 (02) 334-341
    CrossrefPubMedGoogle Scholar
  • 35 Iber C, Sirr S. Diagnosis of pulmonary embolism. Semin Respir Infect 1988; 3 (03) 203-216
    PubMedGoogle Scholar
  • 36 Afzal A, Noor HA, Gill SA, Brawner C, Stein PD. Leukocytosis in acute pulmonary embolism. Chest 1999; 115 (05) 1329-1332
    CrossrefPubMedGoogle Scholar